Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Buy
60
RRR Quote, Financials, Valuation and Earnings
Last price:
$45.75
Seasonality move
:
9.15%
Day range:
$46.21 - $47.00
52-week range:
$35.09 - $61.73
Dividend yield:
2.15%
P/E ratio:
18.01x
P/S ratio:
2.21x
P/B ratio:
11.30x
Volume:
689K
Avg. volume:
712.3K
1-year change:
-9.45%
Market cap:
$2.8B
Revenue:
$1.9B
EPS (TTM):
$2.58
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.6B | $1.7B | $1.7B | $1.9B | |
| Revenue Growth (YoY) | -36.31% | 36.83% | 2.84% | 3.62% | 12.47% | |
| Cost of Revenues | $501.3M | $552.5M | $588.7M | $626.4M | $744.2M | |
| Gross Profit | $681.1M | $1.1B | $1.1B | $1.1B | $1.2B | |
| Gross Profit Margin | 57.61% | 65.85% | 64.62% | 63.67% | 61.62% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $324.6M | $347.1M | $353M | $374.5M | $432.3M | |
| Other Inc / (Exp) | -$57.1M | -$171.8M | -$28.9M | -$28.9M | -$18.4M | |
| Operating Expenses | $556M | $504.9M | $481.4M | $507M | $619.4M | |
| Operating Income | $125.1M | $560.5M | $593.7M | $590.7M | $575.4M | |
| Net Interest Expenses | $128.5M | $103.2M | $129.9M | $181M | $228.8M | |
| EBT. Incl. Unusual Items | -$60.5M | $285.5M | $434.9M | $380.8M | $328.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $114.1M | -$69.3M | $44.5M | $43M | $36.9M | |
| Net Income to Company | -$174.5M | $354.8M | $390.4M | $337.8M | $291.3M | |
| Minority Interest in Earnings | $24.1M | -$113M | -$184.9M | -$161.8M | -$137.2M | |
| Net Income to Common Excl Extra Items | -$150.4M | $241.9M | $205.5M | $176M | $154.1M | |
| Basic EPS (Cont. Ops) | -$2.13 | $3.50 | $3.48 | $3.04 | $2.61 | |
| Diluted EPS (Cont. Ops) | -$2.13 | $2.84 | $3.36 | $2.94 | $2.53 | |
| Weighted Average Basic Share | $70.5M | $69.1M | $59M | $57.9M | $59M | |
| Weighted Average Diluted Share | $70.5M | $116.5M | $104.7M | $103.2M | $103.7M | |
| EBITDA | $299.4M | $546.5M | $693.1M | $694.3M | $744.1M | |
| EBIT | $68M | $388.7M | $564.8M | $561.8M | $557M | |
| Revenue (Reported) | $1.2B | $1.6B | $1.7B | $1.7B | $1.9B | |
| Operating Income (Reported) | $125.1M | $560.5M | $593.7M | $590.7M | $575.4M | |
| Operating Income (Adjusted) | $68M | $388.7M | $564.8M | $561.8M | $557M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $352.6M | $401.6M | $433.6M | $488.9M | $497.9M | |
| Revenue Growth (YoY) | -6.56% | 13.9% | 7.97% | 12.74% | 1.83% | |
| Cost of Revenues | $120.6M | $140.9M | $153.1M | $181.6M | $186.4M | |
| Gross Profit | $232M | $260.7M | $280.5M | $307.3M | $311.5M | |
| Gross Profit Margin | 65.8% | 64.91% | 64.68% | 62.87% | 62.56% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $78.9M | $86.3M | $92.5M | $104.8M | $104.7M | |
| Other Inc / (Exp) | -$177.9M | -$9.3M | -$18.7M | -$15.8M | -$8.5M | |
| Operating Expenses | $133.2M | $119.7M | $123.6M | $149.7M | $153M | |
| Operating Income | $98.8M | $141M | $156.9M | $157.7M | $158.4M | |
| Net Interest Expenses | $27.3M | $26.7M | $42.5M | $57.2M | $51.1M | |
| EBT. Incl. Unusual Items | -$106.3M | $105M | $95.7M | $84.6M | $98.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $217K | $12.7M | $10.2M | $6.3M | $12.8M | |
| Net Income to Company | -$106.6M | $92.2M | $85.5M | $78.4M | $86M | |
| Minority Interest in Earnings | $41.8M | -$43.9M | -$40.9M | -$35.5M | -$41.2M | |
| Net Income to Common Excl Extra Items | -$64.8M | $48.3M | $44.7M | $42.8M | $44.7M | |
| Basic EPS (Cont. Ops) | -$0.92 | $0.79 | $0.77 | $0.73 | $0.76 | |
| Diluted EPS (Cont. Ops) | -$0.92 | $0.77 | $0.75 | $0.68 | $0.75 | |
| Weighted Average Basic Share | $70.7M | $61M | $57.7M | $58.8M | $59.2M | |
| Weighted Average Diluted Share | $70.7M | $107.7M | $103.2M | $103.7M | $103.4M | |
| EBITDA | -$24.8M | $165.1M | $169.3M | $186.7M | $198.2M | |
| EBIT | -$79.1M | $131.6M | $138.2M | $141.8M | $149.9M | |
| Revenue (Reported) | $352.6M | $401.6M | $433.6M | $488.9M | $497.9M | |
| Operating Income (Reported) | $98.8M | $141M | $156.9M | $157.7M | $158.4M | |
| Operating Income (Adjusted) | -$79.1M | $131.6M | $138.2M | $141.8M | $149.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.7B | $1.7B | $1.8B | $1.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $415.8M | $572.8M | $600.9M | $654.8M | $749.1M | |
| Gross Profit | $741.8M | $1.1B | $1.1B | $1.1B | $1.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $302.3M | $354.5M | $359.3M | $386.8M | $432.2M | |
| Other Inc / (Exp) | -$195M | -$3.2M | -$38.3M | -$26M | -$11.1M | |
| Operating Expenses | $529.4M | $491.4M | $485.3M | $533.1M | $622.8M | |
| Operating Income | $212.4M | $602.7M | $609.6M | $591.4M | $576.1M | |
| Net Interest Expenses | $119.7M | $102.6M | $145.7M | $195.8M | $222.7M | |
| EBT. Incl. Unusual Items | -$102.2M | $496.9M | $425.6M | $369.7M | $342.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.1M | -$56.8M | $42M | $39.1M | $43.5M | |
| Net Income to Company | -$103.3M | $553.6M | $383.6M | $330.6M | $298.9M | |
| Minority Interest in Earnings | $40.3M | -$198.7M | -$181.8M | -$156.5M | -$142.9M | |
| Net Income to Common Excl Extra Items | -$63M | $355M | $201.8M | $174.2M | $156M | |
| Basic EPS (Cont. Ops) | -$0.89 | $5.30 | $3.48 | $2.99 | $2.64 | |
| Diluted EPS (Cont. Ops) | -$0.98 | $4.48 | $3.33 | $2.88 | $2.58 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $244.6M | $736.4M | $697.3M | $711.8M | $755.6M | |
| EBIT | $17.5M | $599.5M | $571.3M | $565.5M | $565M | |
| Revenue (Reported) | $1.2B | $1.7B | $1.7B | $1.8B | $1.9B | |
| Operating Income (Reported) | $212.4M | $602.7M | $609.6M | $591.4M | $576.1M | |
| Operating Income (Adjusted) | $17.5M | $599.5M | $571.3M | $565.5M | $565M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $352.6M | $401.6M | $433.6M | $488.9M | $497.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $120.6M | $140.9M | $153.1M | $181.6M | $186.4M | |
| Gross Profit | $232M | $260.7M | $280.5M | $307.3M | $311.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $78.9M | $86.3M | $92.5M | $104.8M | $104.7M | |
| Other Inc / (Exp) | -$177.9M | -$9.3M | -$18.7M | -$15.8M | -$8.5M | |
| Operating Expenses | $133.2M | $119.7M | $123.6M | $149.7M | $153M | |
| Operating Income | $98.8M | $141M | $156.9M | $157.7M | $158.4M | |
| Net Interest Expenses | $27.3M | $26.7M | $42.5M | $57.2M | $51.1M | |
| EBT. Incl. Unusual Items | -$106.3M | $105M | $95.7M | $84.6M | $98.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $217K | $12.7M | $10.2M | $6.3M | $12.8M | |
| Net Income to Company | -$106.6M | $92.2M | $85.5M | $78.4M | $86M | |
| Minority Interest in Earnings | $41.8M | -$43.9M | -$40.9M | -$35.5M | -$41.2M | |
| Net Income to Common Excl Extra Items | -$64.8M | $48.3M | $44.7M | $42.8M | $44.7M | |
| Basic EPS (Cont. Ops) | -$0.92 | $0.79 | $0.77 | $0.73 | $0.76 | |
| Diluted EPS (Cont. Ops) | -$0.92 | $0.77 | $0.75 | $0.68 | $0.75 | |
| Weighted Average Basic Share | $70.7M | $61M | $57.7M | $58.8M | $59.2M | |
| Weighted Average Diluted Share | $70.7M | $107.7M | $103.2M | $103.7M | $103.4M | |
| EBITDA | -$24.8M | $165.1M | $169.3M | $186.7M | $198.2M | |
| EBIT | -$79.1M | $131.6M | $138.2M | $141.8M | $149.9M | |
| Revenue (Reported) | $352.6M | $401.6M | $433.6M | $488.9M | $497.9M | |
| Operating Income (Reported) | $98.8M | $141M | $156.9M | $157.7M | $158.4M | |
| Operating Income (Adjusted) | -$79.1M | $131.6M | $138.2M | $141.8M | $149.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $121.2M | $275.3M | $117.3M | $137.6M | $164.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $35.1M | $36.7M | $43.6M | $61.9M | $64.4M | |
| Inventory | $13.1M | $11.7M | $13.2M | $15.3M | $16.4M | |
| Prepaid Expenses | $24.3M | $26.7M | $22.8M | $24.9M | $27.7M | |
| Other Current Assets | $13.8M | $20.4M | $24M | $28.2M | $22.5M | |
| Total Current Assets | $224.7M | $378.5M | $221M | $282.3M | $295.4M | |
| Property Plant And Equipment | $2.9B | $2B | $2.2B | $2.8B | $2.8B | |
| Long-Term Investments | $8.2M | -- | -- | -- | -- | |
| Goodwill | $195.7M | $195.7M | $195.7M | $195.7M | $195.7M | |
| Other Intangibles | $100.8M | $87.2M | $84.4M | $82.8M | $81.2M | |
| Other Long-Term Assets | $72.5M | $99.3M | $83.2M | $81.7M | $85.5M | |
| Total Assets | $3.7B | $3.1B | $3.3B | $4B | $4B | |
| Accounts Payable | $11.2M | $17.5M | $11.4M | $25.4M | $31.8M | |
| Accrued Expenses | $135.9M | $127.1M | $131.7M | $151.5M | $179.2M | |
| Current Portion Of Long-Term Debt | $22.8M | $25.9M | $26.1M | $26.1M | $52.9M | |
| Current Portion Of Capital Lease Obligations | $2.9M | $3M | $4.8M | $6.1M | $6.4M | |
| Other Current Liabilities | $11.8M | -- | -- | -- | -- | |
| Total Current Liabilities | $200.3M | $204.8M | $293.2M | $349.2M | $325.2M | |
| Long-Term Debt | $2.9B | $2.8B | $3B | $3.3B | $3.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.1B | $3.1B | $3.3B | $3.7B | $3.7B | |
| Common Stock | $713K | $615K | $581K | $590K | $597K | |
| Other Common Equity Adj | -$623K | -- | -- | -- | -- | |
| Common Equity | $352.6M | $59.5M | $43.8M | $168.8M | $215.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $252M | -$9.5M | -$11.5M | $75M | $91.8M | |
| Total Equity | $604.6M | $50M | $32.2M | $243.9M | $306.8M | |
| Total Liabilities and Equity | $3.7B | $3.1B | $3.3B | $4B | $4B | |
| Cash and Short Terms | $121.2M | $275.3M | $117.3M | $137.6M | $164.4M | |
| Total Debt | $2.9B | $2.9B | $3B | $3.3B | $3.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $117.9M | $336.6M | $107.7M | $129.7M | $150.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $35.4M | $34.9M | $44.1M | $62.6M | $68.9M | |
| Inventory | $12.4M | $11.9M | $13.4M | $16M | $16.3M | |
| Prepaid Expenses | $26.2M | $27.6M | $25.6M | $28.4M | $28.2M | |
| Other Current Assets | $19M | $19.5M | $27.3M | $30.5M | $27.8M | |
| Total Current Assets | $890.1M | $470M | $218.1M | $275.3M | $291.9M | |
| Property Plant And Equipment | $2B | $2B | $2.4B | $2.8B | $2.8B | |
| Long-Term Investments | $7.6M | $5.9M | -- | -- | -- | |
| Goodwill | $195.7M | $195.7M | $195.7M | $195.7M | $195.7M | |
| Other Intangibles | $88.4M | $86.8M | $84M | $82.4M | $80.8M | |
| Other Long-Term Assets | $64.7M | $62.5M | $85.6M | $88.8M | $86.5M | |
| Total Assets | $3.5B | $3.2B | $3.5B | $4B | $4.1B | |
| Accounts Payable | $10.4M | $18.2M | $16.4M | $19.5M | $27.6M | |
| Accrued Expenses | $129.6M | $139.3M | $136.8M | $156.1M | $155.9M | |
| Current Portion Of Long-Term Debt | $26.4M | $25.9M | $26.1M | $17M | $52.6M | |
| Current Portion Of Capital Lease Obligations | $3.2M | $3.1M | $5.5M | $6.1M | $6.5M | |
| Other Current Liabilities | $10.8M | -- | -- | -- | -- | |
| Total Current Liabilities | $200.1M | $236.8M | $335.8M | $306.9M | $315.6M | |
| Long-Term Debt | $2.8B | $2.8B | $3B | $3.4B | $3.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.1B | $3.1B | $3.4B | $3.8B | $3.7B | |
| Common Stock | $711K | $616K | $583K | $597K | $602K | |
| Other Common Equity Adj | -$624K | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $202.3M | $9M | $18.6M | $50.2M | $122.5M | |
| Total Equity | $477.8M | $96.8M | $93.6M | $185.5M | $369.6M | |
| Total Liabilities and Equity | $3.5B | $3.2B | $3.5B | $4B | $4.1B | |
| Cash and Short Terms | $117.9M | $336.6M | $107.7M | $129.7M | $150.6M | |
| Total Debt | $2.8B | $2.8B | $3.1B | $3.4B | $3.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$174.5M | $354.8M | $390.4M | $337.8M | $291.3M | |
| Depreciation & Amoritzation | $231.4M | $157.8M | $128.4M | $132.5M | $187.1M | |
| Stock-Based Compensation | $10.9M | $12.7M | $17.5M | $19.7M | $30.9M | |
| Change in Accounts Receivable | $16.4M | -$1.3M | -$4.2M | -$18.3M | -$2.5M | |
| Change in Inventories | $10.3M | -$14.4M | -$6.3M | -$8M | $2M | |
| Cash From Operations | $212.8M | $610M | $542.2M | $494.3M | $548.3M | |
| Capital Expenditures | $58.5M | $65.9M | $561.3M | $701.6M | $298.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$69.6M | $586.3M | -$442.1M | -$653.9M | -$321.8M | |
| Dividends Paid (Ex Special Dividend) | -$7.3M | -$203.8M | -$116.7M | -$58.6M | -$118.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.8B | $1.2B | $297.5M | $476.5M | $2.5B | |
| Long-Term Debt Repaid | -$1.9B | -$1.2B | -$172.8M | -$138.8M | -$2.4B | |
| Repurchase of Common Stock | -- | -$500.2M | -$141.5M | -- | -$3.9M | |
| Other Financing Activities | -$20M | -$260.2M | -$156.6M | -$99.3M | -$167.1M | |
| Cash From Financing | -$150.4M | -$1B | -$290M | $179.8M | -$199.7M | |
| Beginning Cash (CF) | $132.9M | $125.7M | $307.3M | $117.3M | $137.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$7.2M | $181.6M | -$190M | $20.3M | $26.8M | |
| Ending Cash (CF) | $125.7M | $307.3M | $117.3M | $137.6M | $164.4M | |
| Levered Free Cash Flow | $154.3M | $544M | -$19.1M | -$207.3M | $249.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$106.6M | $92.2M | $85.5M | $78.4M | $86M | |
| Depreciation & Amoritzation | $54.3M | $33.4M | $31.1M | $44.9M | $48.3M | |
| Stock-Based Compensation | $2.7M | $3.5M | $5.3M | $5.9M | $7.6M | |
| Change in Accounts Receivable | -$167K | $1.9M | -$450K | -$665K | -$4.5M | |
| Change in Inventories | -$7.5M | -$1.9M | -$5.5M | -$7.9M | -$6.3M | |
| Cash From Operations | $119.8M | $157.5M | $140.5M | $126.5M | $126.2M | |
| Capital Expenditures | $8M | $38.9M | $177.6M | $98.1M | $68.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$16.3M | -$40.1M | -$180M | -$100M | -$92.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -$15.8M | -$15M | -$74.1M | -$16M | |
| Special Dividend Paid | -- | -- | -- | $1M | -- | |
| Long-Term Debt Issued | $220M | -- | $73M | $2.4B | $70M | |
| Long-Term Debt Repaid | -$303.9M | -$6.2M | -$6.2M | -$2.3B | -$83.9M | |
| Repurchase of Common Stock | -$11.7M | -$8.8M | -- | -- | -- | |
| Other Financing Activities | -$11M | -$25.2M | -$21.9M | -$91.8M | -$17.6M | |
| Cash From Financing | -$106.6M | -$56M | $29.9M | -$34.3M | -$47.4M | |
| Beginning Cash (CF) | $125.7M | $307.3M | $117.3M | $137.6M | $164.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$3.1M | $61.3M | -$9.6M | -$7.9M | -$13.7M | |
| Ending Cash (CF) | $122.6M | $368.5M | $107.7M | $129.7M | $150.6M | |
| Levered Free Cash Flow | $111.8M | $118.5M | -$37.1M | $28.4M | $58M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$103.3M | $553.6M | $383.6M | $330.6M | $298.9M | |
| Depreciation & Amoritzation | $227.1M | $137M | $126M | $146.3M | $190.6M | |
| Stock-Based Compensation | $9.6M | $13.5M | $19.3M | $20.3M | $32.7M | |
| Change in Accounts Receivable | $62K | $723K | -$6.5M | -$18.5M | -$6.3M | |
| Change in Inventories | $3.4M | -$8.8M | -$9.9M | -$10.4M | $3.7M | |
| Cash From Operations | $284.7M | $647.7M | $525.3M | $480.3M | $548M | |
| Capital Expenditures | $35.7M | $96.9M | $700M | $622.1M | $269M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$54.5M | $562.4M | -$582M | -$573.9M | -$314.3M | |
| Dividends Paid (Ex Special Dividend) | -$197K | -$219.6M | -$115.9M | -$117.6M | -$60.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $270M | $955M | $370.5M | $2.8B | $190M | |
| Long-Term Debt Repaid | -$1.4B | -$928.9M | -$172.8M | -$2.4B | -$245.7M | |
| Repurchase of Common Stock | -$11.6M | -$497.3M | -- | -- | -- | |
| Other Financing Activities | -$14.3M | -$274.5M | -$153.2M | -$169.2M | -$92.9M | |
| Cash From Financing | -$1.2B | -$964.1M | -$204.1M | $115.6M | -$212.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$972.7M | $246M | -$260.8M | $22M | $20.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $249M | $550.8M | -$174.7M | -$141.8M | $279M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$106.6M | $92.2M | $85.5M | $78.4M | $86M | |
| Depreciation & Amoritzation | $54.3M | $33.4M | $31.1M | $44.9M | $48.3M | |
| Stock-Based Compensation | $2.7M | $3.5M | $5.3M | $5.9M | $7.6M | |
| Change in Accounts Receivable | -$167K | $1.9M | -$450K | -$665K | -$4.5M | |
| Change in Inventories | -$7.5M | -$1.9M | -$5.5M | -$7.9M | -$6.3M | |
| Cash From Operations | $119.8M | $157.5M | $140.5M | $126.5M | $126.2M | |
| Capital Expenditures | $8M | $38.9M | $177.6M | $98.1M | $68.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$16.3M | -$40.1M | -$180M | -$100M | -$92.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -$15.8M | -$15M | -$74.1M | -$16M | |
| Special Dividend Paid | -- | -- | -- | $1M | -- | |
| Long-Term Debt Issued | $220M | -- | $73M | $2.4B | $70M | |
| Long-Term Debt Repaid | -$303.9M | -$6.2M | -$6.2M | -$2.3B | -$83.9M | |
| Repurchase of Common Stock | -$11.7M | -$8.8M | -- | -- | -- | |
| Other Financing Activities | -$11M | -$25.2M | -$21.9M | -$91.8M | -$17.6M | |
| Cash From Financing | -$106.6M | -$56M | $29.9M | -$34.3M | -$47.4M | |
| Beginning Cash (CF) | $125.7M | $307.3M | $117.3M | $137.6M | $164.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$3.1M | $61.3M | -$9.6M | -$7.9M | -$13.7M | |
| Ending Cash (CF) | $122.6M | $368.5M | $107.7M | $129.7M | $150.6M | |
| Levered Free Cash Flow | $111.8M | $118.5M | -$37.1M | $28.4M | $58M | |
Get RRR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RRR
Sector
P/E ratio
18.01x
16.62x
PEG ratio
--
0.18x
P/B ratio
11.30x
1.34x
Price / LTM sales
2.21x
0.67x
Growth Metrics
RRR
Sector
Revenue growth
1.83%
1.1%
Earnings growth
10.29%
-1.65%
Revenue (5-year growth)
0.87%
3.6%
Earnings forecast
$0.45
$0.21
Profitability
RRR
Sector
Profitability FY 2024
$1.2B
$482.3M
Return on invested capital
4.23%
4.76%
Return on assets
3.88%
2.84%
Return on equity
58.75%
7.28%
Earnings Date
Last Earnings Date
May
1
Next Earnings Date
Jul
23
Estimated Next Earnings Date
Jul
31
Balance Sheet
RRR
Sector
Total cash
$150.6M
$148.2M
Short term investments
--
$50M
Total assets
$4B
$1.5B
Long term debt
$3.4B
$141.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
99
SOC alert for May 20
Sable Offshore [SOC] is down 0.79% over the past day.
Buy
52
RGC alert for May 20
Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.
Sell
40
GWLIF alert for May 20
Great-West Lifeco [GWLIF] is up 13.42% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
